Saturday, August 23rd14.6°C
22568
21705

J&J receives $4.15 billion offer for Ortho-Clinical Diagnostics business from Carlyle Group

TRENTON, N.J. - Johnson & Johnson said Thursday that it's been offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business, a year after J&J began reviewing strategic options for the blood-testing unit as part of a routine pruning of its extensive family of businesses.

J&J, based in New Brunswick, N.J., has until March 31 to decide whether to accept the offer. Johnson & Johnson executives plan to discuss the offer Tuesday, when the health giant and consumer products company reports fourth-quarter results. The company said Thursday that it will consult with works councils and trade unions representing the unit's employees before making a decision.

The Ortho-Clinical business serves hospitals, testing laboratories and blood banks.

One division supplies equipment and chemicals to screen donated blood for HIV, hepatitis C and other serious diseases, and for typing donated blood to ensure patients get safe, compatible blood transfusions. The other division makes technology for advanced testing of blood to diagnose a range of health conditions and to monitor the effects of medication.

Established in 1937, Ortho Clinical Diagnostics is based in Raritan, N.J., and has factories in Rochester, N.Y.; Pompano Beach, Fla., and Pencoed, Wales. It has more than 4,500 employees and operates in more than 30 countries worldwide.

Last January, CEO Alex Gorsky said J&J was looking at strategic options for Ortho-Clinical Diagnostics, which doesn't meet the company's long-held strategy of focusing on businesses that rank first or second in their markets.

In 2012, J&J reported revenue of $2.1 billion for the diagnostics business, down more than 4 per cent from 2011. Revenue fell even more over the first nine months of 2013, when it was down 8 per cent from the prior year at $1.42 billion.

Carlyle Group is a private equity and buyout firm based in Washington, D.C. If the sale goes through, Carlyle is expected to try to expand the business through increased marketing and creation of new products. Carlyle manages more than $185 billion worth of assets worldwide, according to its website.

In afternooon trading, Carlyle shares were up 1 cent at $37. Johnson & Johnson shares were down 25 cents at $94.55. The stock has seen a tremendous run-up since Gorsky took over in April 2012, with shares rising 46 per cent from $64.75 back then.

___

AP Business Writer Tom Murphy in Indianapolis contributed to this report.

The Canadian Press


Read more Business News

21337


Recent Trending




Today's Market
S&P TSX15535.55-19.71
S&P CDNX1005.583.38
DJIA17001.22-38.27
Nasdaq4538.551+6.446
S&P 5001988.40-3.97
CDN Dollar0.9137-0.0003
Gold1279.90+6.2001
Oil96.30+1.82
Lumber352.80-2.80
Natural Gas3.88-0.009

 
Okanagan Companies
Pacific Safety0.18-0.005
Knighthawk0.01-0.005
QHR Technologies Inc1.20-0.01
Cantex0.065-0.005
Anavex Life Sciences0.265+0.005
Metalex Ventures0.08+0.005
Russel Metals36.78-0.81
Copper Mountain Mining2.99+0.11
Colorado Resources0.17-0.015
ReliaBrand Inc0.115+0.02
Sunrise Resources Ltd0.025-0.005
Mission Ready Services0.26+0.045

 



22942

FEATURED Property
20055472680 Arthur Road
4 bedrooms 3 baths
$829,000
more details
image2image2image2
Click here to feature your property
Please wait... loading


How much mortgage should you carry?

There are several things to consider when deciding how much home to buy. 1. Draw up a budget including the new mortgage payments. While the rules used by most lenders require that the mortgage paym...


What is a journey without a destination?

Photo: ContributedI would call it a joy ride... You see a planned project or business has a destination. It may be an ongoing revenue stream, it may be a business value or an exit strategy. If you don...


Joint accounts: what you need to know!

Establishing a joint account may seem like a great strategy at first glance. However, there are many factors that must be considered before taking this action. This article will explore the use of &ls...

_



22854

22885


Member of BC Press Council


22837